These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 621817)

  • 1. Adjuvant chemotherapy for bladder cancer with doxorubicin hydrochloride and cyclophosphamide: preliminary report.
    Merrin C; Beckley S
    J Urol; 1978 Jan; 119(1):62-3. PubMed ID: 621817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin.
    Merrin C; Cartagena R; Wajsman Z; Baumgartner G; Murphy GP
    J Urol; 1975 Dec; 114(6):884-7. PubMed ID: 1195468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy of bladder cancer: a preliminary report.
    Logothetis CJ; Johnson DE; Chong C; Dexeus FH; Ogden S; von Eschenbach A; Ayala A
    J Urol; 1988 Jun; 139(6):1207-11. PubMed ID: 3373589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant doxorubicin hydrochloride and radiation in stage D bladder cancer: a preliminary report.
    Schaeffer AJ; Grayhack JT; Merrill JM; Kies MS; Bulkley GJ; Shetty RM; Chmiel JS
    J Urol; 1984 Jun; 131(6):1073-6. PubMed ID: 6726904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
    Collier D; Soloway MS
    Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
    Smalley RV; Bartolucci AA; Hemstreet G; Hester M
    J Urol; 1981 Feb; 125(2):191-5. PubMed ID: 7206052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.
    Kurth KH; Schröder FH; Tunn U; Ay R; Pavone-Macaluso M; Debruyne F; de Pauw M; Dalesio O; ten Kate F
    J Urol; 1984 Aug; 132(2):258-62. PubMed ID: 6376827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
    Seguchi T; Sakaguchi H; Kajikawa H; Nishioka T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):600-5. PubMed ID: 2435245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination radiotherapy and chemotherapy in murine bladder cancer.
    Weldon TE; Kursh E; Novak LJ; Persky L
    Urology; 1979 Jul; 14(1):47 52. PubMed ID: 452220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M; Kotake T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
    Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC
    J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
    Seski JC; Edwards CL; Gershenson DM; Copeland LJ
    Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
    Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
    Yagoda A
    Cancer Res; 1977 Aug; 37(8 Pt 2):2775-80. PubMed ID: 68814
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of stage D bladder cancer with adjuvant doxorubicin hydrochloride and radiation.
    Schaeffer AJ; Grayhack JT; Merrill JM; Bulkley GJ; Shetty RM
    Urology; 1982 Oct; 20(4):393-400. PubMed ID: 6755854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.
    Buzdar AU; Blumenschein GR; Gutterman JU; Tashima CK; Hortobagyi GN; Smith TL; Campos LT; Wheeler WL; Hersh EM; Freireich EJ; Gehan EA
    JAMA; 1979 Oct; 242(14):1509-13. PubMed ID: 470088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.
    Logothetis CJ; Johnson DE; Chong C; Dexeus FH; Sella A; Ogden S; Smith T; Swanson DA; Babaian RJ; Wishnow KI
    J Clin Oncol; 1988 Oct; 6(10):1590-6. PubMed ID: 3171626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant chemotherapy using adriamycin and cisplatin in infiltrating cancer of the bladder. Prospective study of 49 cases].
    Azab M; Theodore C; Cukier J; Beurton D; Gilles E; Droz JP
    J Urol (Paris); 1989; 95(8):459-63. PubMed ID: 2607167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.